CINECA IRIS Institutional Research Information System

BROGLIO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.785
EU - Europa 5.867
AS - Asia 3.480
SA - Sud America 345
OC - Oceania 160
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.497
CN - Cina 1.451
IT - Italia 887
DE - Germania 699
IE - Irlanda 663
UA - Ucraina 661
SG - Singapore 621
FR - Francia 545
SE - Svezia 539
GB - Regno Unito 421
FI - Finlandia 404
KR - Corea 392
BR - Brasile 234
PL - Polonia 221
JP - Giappone 212
AT - Austria 209
CA - Canada 207
AU - Australia 142
ES - Italia 139
VN - Vietnam 130
NL - Olanda 105
IN - India 102
TR - Turchia 100
ID - Indonesia 87
RU - Federazione Russa 82
HK - Hong Kong 67
BE - Belgio 66
MX - Messico 63
PH - Filippine 54
TW - Taiwan 45
IL - Israele 39
CL - Cile 36
MY - Malesia 35
PT - Portogallo 34
AR - Argentina 31
CH - Svizzera 30
GR - Grecia 28
HU - Ungheria 27
DK - Danimarca 26
JO - Giordania 23
RO - Romania 22
IR - Iran 20
TH - Thailandia 19
CO - Colombia 18
NZ - Nuova Zelanda 18
UZ - Uzbekistan 16
NO - Norvegia 14
PE - Perù 13
EG - Egitto 12
SN - Senegal 12
LB - Libano 9
QA - Qatar 8
RS - Serbia 8
SA - Arabia Saudita 7
SI - Slovenia 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
MA - Marocco 6
PK - Pakistan 6
ZA - Sudafrica 6
CY - Cipro 5
EU - Europa 5
BG - Bulgaria 4
EC - Ecuador 4
GE - Georgia 4
GT - Guatemala 4
KZ - Kazakistan 4
LT - Lituania 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AN - Antille olandesi 3
BD - Bangladesh 3
EE - Estonia 3
MK - Macedonia 3
SC - Seychelles 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
LK - Sri Lanka 2
MU - Mauritius 2
MV - Maldive 2
NG - Nigeria 2
NP - Nepal 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
ET - Etiopia 1
Totale 18.686
Salva come PNG Salva come JPEG
Città #
Beijing 1.005
Chandler 885
Dublin 647
Santa Clara 641
Singapore 492
Houston 451
Jacksonville 367
Villeurbanne 352
Fairfield 288
Redwood City 246
Dearborn 228
Ann Arbor 221
Princeton 214
Medford 213
Ashburn 209
Wilmington 199
Vienna 192
Columbus 188
Nyköping 188
Warsaw 175
Torino 144
Milan 128
Woodbridge 126
Boston 120
Seattle 115
Cambridge 107
Fremont 83
Boardman 71
Pisa 68
Dong Ket 67
Turin 67
Toronto 63
Verona 60
Jakarta 49
Tokyo 40
São Paulo 39
Norwalk 38
Shanghai 38
Nanjing 37
Guangzhou 35
Brussels 33
Lachine 31
London 31
New York 31
Hefei 27
Mountain View 26
Taipei 26
Ankara 24
Munich 24
Washington 24
Falls Church 23
Santiago 23
Amsterdam 20
Sydney 20
Istanbul 19
San Diego 19
Detroit 18
Helsinki 17
Menlo Park 17
San Mateo 17
Seoul 17
Cupertino 16
Duncan 16
Frankfurt am Main 16
Jinan 16
Melbourne 16
Rome 16
Central District 15
Hangzhou 15
Los Angeles 15
Moscow 15
Zhengzhou 15
Berlin 14
Buenos Aires 14
Kuala Lumpur 14
Absecon 13
Düsseldorf 13
Ottawa 13
Wuhan 13
Birmingham 12
Central 12
Izmir 12
Kunming 12
Montreal 12
Padova 12
Redmond 12
Budapest 11
Chicago 11
Guadalajara 11
Hong Kong 11
Kiel 11
Philadelphia 11
Polska 11
Pune 11
Chengdu 10
Fuzhou 10
Mexico 10
Nanchang 10
Alcalá De Henares 9
Barcelona 9
Totale 9.878
Salva come PNG Salva come JPEG
Nome #
Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study 2.527
Timing of food intake: sounding the alarm about metabolic impairments? A systematic review. 1.311
Effects of Self-Conditioning Techniques (Self-Hypnosis) in Promoting Weight Loss in Patients with Severe Obesity: A Randomized Controlled Trial 576
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 462
Effects of Self-Conditioning Techniques (Self-Hypnosis) in Promoting Weight Loss in Patients with Severe Obesity: A Randomized Controlled Trial 388
Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects. 305
Impaired taste sensation in type 2 diabetic patients without chronic complications: a case-control study 270
Ghrelin 218
Predictive role of the Mediterranean diet on mortality in individuals at low cardiovascular risk: A 12-year follow-up population-based cohort study 205
Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (GDM) 197
Acute effects of acylated ghrelin on salbutamol-induced metabolic actions in humans 187
The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. 168
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase 168
Effects of meal timing on changes in circulating epinephrine, norepinephrine, and acylated ghrelin concentrations: A pilot study 166
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up 153
Changes in weight and nutritional habits in adults with obesity during the “lockdown” period caused by the COVID-19 virus emergency 135
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 126
Dietary interventions modify the gut microbiota during pregnancy in patients with gestational diabetes mellitus (GDM) 119
Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans 115
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy 113
Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of delivery. 105
Testing pituitary function in aging individuals 103
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans 102
Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans 101
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 101
The nutritional status has no major role in the age-related reduction of IGF-I secretion. 100
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. 99
The metabolic response to the activation ofthe beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin 99
Endocrine and metabolic response to extreme altitude and physical exercise in athletes. 99
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences 94
MEDIATORI CENTRALI E PERIFERICI DEL COMPORTAMENTO ALIMENTARE 94
The GH response to GHRH in normal adults is not affected by enalapril or furosemide while is blunted by digoxin. 93
Cardiac effects of hexarelin in hypopituitary adults. 92
Sleep abnormalities in type 2 diabetes may be associated with glycemic control 91
Ghrelin: endocrine, metabolic and cardiovascular actions 91
Primary hyperparathyroidism is associated with an impaired secretion of growth hormone but not of the other anterior pituitary hormones. 90
Biologic activities of growth hormone secretagogues in humans. 90
The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans 90
Self-reported adherence to diet and preferences towards type of meal plan in patient with type 2 diabetes mellitus. A cross-sectional study. 90
Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. 89
ACTIVITY OF GH/IGF-I AXIS IN PATIENTS WITH DILATED CARDIOMYOPATHY 89
Acetylcholine regulates ghrelin secretion in humans 89
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma 88
Activity of GH/IGF-I axis in burn patients: comparison with normal subjects and patients with growth hormone deficiency. 86
GHRELIN SECRETION IS INHIBITED BY GLUCOSE LOAD AND INSULIN-INDUCED HYPOGLYCEMIA BUT UNAFFECTED BY GLUCAGON AND ARGININE IN HUMANS 85
d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans 85
CORTICOTROPH AND ADRENAL RESPONSIVENESS TO hCRH, HEXARELIN AND ACTH IN YOUNG AND ELDERLY SUBJECTS 84
Circulating obestatin levels in normal and Type 2 diabetic subjects. 84
Ghrelin: much more than a natural growth hormone secretagogue. 83
Type 2 diabetes mellitus is associated with disruptions as a function of metabolic control. 83
Continuous glucose monitoring is more effective than mixed meal test in the diagnosis of post-gastric bypass reactive hypoglycemia 83
Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers. 83
Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. 82
Beta-adrenergic agonism does not impair the GH response to acylated ghrelin inhumans 81
Is HDL cholesterol protective in patients with type 2 diabetes? A retrospective population-based cohort study 81
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. 80
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 80
GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. 80
Ghrelin inhibits LH pulsatile secretion in humans. 80
Age-related variations of the GH response to GH secretagogues in humans. 79
Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis 79
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 79
Endocrine and metabolic actions of ghrelin 79
Brain-gut communication: cortistatin, somatostatin and ghrelin 79
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors 77
EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. 77
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy 77
Other than Growth Hormone Neuroendocrine Actions of Ghrelin 77
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. 77
Presence of cortistatin in the human pancreas. 76
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 76
Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes 73
In Patients with Obesity, Are Affective Temperaments Associated with Attrition? An Evaluation during and before the SARS-CoV-2 Pandemic 73
GH secretion is impaired in patients with primary hyperparathyroidism. 72
Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults. 72
Ghrelin and synthetic GH secretagogues. 72
Cardiac effects of hexarelin in hypopituitary adults 72
Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations 72
Continuous glucose monitoring is more effective than mixed meal test in the diagnosis of post-gastric by pass reactive hypoglycemia 72
Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy. 71
Myocardial Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Gene Expression in Failing Hearts Harvested From Patients Undergoing Cardiac Transplantation 71
AZIONI ENDOCRINE E EXTRA-ENDOCRINE DI GHRELIN E DEI GHS SINTETICI 71
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 70
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans 69
Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans 69
Endocrine activities of alexamorelin (Ala-His-d-2-methyl-Trp-Ala-Trp-d-Phe-Lys-NH2), a synthetic GH secretagogue, in humans 69
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. 69
Ormoni dell’ipofisi posteriore 69
METABOLIC MODULATION OF GHRELIN SECRETION IN HUMANS 69
A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score 69
Ghrelin: a new hormone with endocrine and non-endocrine activities 68
Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. 67
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 67
H9c2 cardiac muscle cells express insulin-like growth factor binding protein-3 (IGFBP-3). 66
Known and unknown growth hormone secretagogue receptors and their ligands 65
Ghrelin exerts an inhibitory modulation on LH pulsatility in humans. 65
Ghrelin and anterior pituitary function 65
CARDIOVASCULAR ACTIVITIES OF NATURAL AND SYNTHETIC GH SECRETAGOGUES 65
Ghrelin and other gastrointestinal peptides involved in the control of food intake 65
Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. 64
Totale 14.341
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.368
article - articoli 0
book - libri 0
conference - conferenze 4.588
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.221 0 0 0 0 0 0 299 155 241 211 199 116
2020/20212.383 194 130 220 118 278 121 231 121 288 297 148 237
2021/20222.066 77 100 119 125 146 114 147 120 84 189 338 507
2022/20232.990 335 226 54 276 288 734 276 229 277 69 135 91
2023/20241.341 174 233 98 85 91 129 59 75 23 69 118 187
2024/20252.155 72 319 159 396 970 198 41 0 0 0 0 0
Totale 19.310